Establishment Labs vs Inogen
ESTA and INGN side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ESTA and INGN compare
Establishment Labs is the larger company, worth 14 times as much as Inogen ($2.1B against $151M).
Establishment Labs grew revenue faster over the last twelve months (38.3% versus 13.7% for Inogen).
Inogen keeps more of each dollar of sales as profit, with a net margin of −9.3% compared with −14.6% at Establishment Labs.
Inogen scores higher on the StockData Score (12 against 5 for Establishment Labs), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ESTA | INGN |
|---|---|---|
| Size and price | ||
| Market cap | $2.1B | $151M |
| Share price | $70.75 | $5.69 |
| Change, 1 year | 12.0% | −19.7% |
| Change, 5 years | 9.7% | −82.8% |
| Beta (5Y) | 1.18 | 1.25 |
| Employees | 1,004 | 314 |
| StockData Score | ||
| Total score | 5 | 12 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 3 (better) | 1 |
| Performance score | 1 | 3 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 8.0× | 0.4× (better) |
| P/B | 135× | 1.0× (better) |
| FCF yield | −1.0% (better) | −7.5% |
| Fair value | – | $17.93 |
| Margin of safety | – | 68.3% |
| Growth | ||
| Revenue growth (TTM) | 38.3% (better) | 13.7% |
| Revenue growth, 5Y average | 20.0% (better) | 2.5% |
| Profitability | ||
| Gross margin | 70.2% (better) | 44.1% |
| Operating margin | −6.6% (better) | −11.0% |
| Net margin | −14.6% | −9.3% (better) |
| FCF margin | −8.2% | −3.0% (better) |
| Return on equity | −241% | −20.0% (better) |
| Return on invested capital | −6.7% (better) | −49.2% |
| Financial health | ||
| Debt / equity | 17.17 (better) | 0.00 |
| Interest coverage | −0.6× | – |
| Current ratio | 3.57 (better) | 2.96 |
| Altman Z-score | 2.80 (better) | 1.30 |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 95.8% | 72.9% |
| Held by insiders | 9.6% | 3.7% |
| Insider net buying, 12 months | −$35.5M | −$143K (better) |
| Short interest, % of float | 14.6% | 5.5% |
Go deeper
- ESTA stock overview
- ESTA income statement
- ESTA valuation and score
- INGN stock overview
- INGN income statement
- INGN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.